# Aravax

**Canonical:** https://apis.io/providers/aravax/  
**Website:** https://www.aravax.com.au  
**APIs profiled:** 0

Aravax is a biotechnology company focused on developing next‑generation immunotherapies for food allergies. It aims to revolutionise treatment by using proprietary peptide platforms to retrain the immune system, offering safer and more convenient solutions. The company runs international clinical trials for its lead product PVX108 targeting peanut allergy, with sites in the United States and Australia. Aravax is headquartered in Melbourne, Australia, and also operates in the UK.

## Kin Score — 3.7 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 3.7).

| Facet | Score |
|---|---|
| Discoverability | 48.2 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Aravax Domain Security** — TLSv1.3

## Tags

Biotechnology, Immunotherapy, Food Allergy, Clinical Trials, Australia

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/aravax/). Scores are computed from the provider's own public artifacts under a published rubric.